US2004260064A1PendingUtilityA1

Antibodies to analogs of macrophage stimulating protein and uses thereof

Assignee: AMGEN INCPriority: Dec 16, 1996Filed: Apr 7, 2003Published: Dec 23, 2004
Est. expiryDec 16, 2016(expired)· nominal 20-yr term from priority
Inventors:Robert Wahl
A61K 38/00C07K 14/4753
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Antibodies that specifically bind to Macrophage Stimulating Protein (MSP) analogs are provided. In certain embodiments, these antibodies may be used, for example, to detect MSP analogs in tissues when such analogs are used therapeutically.

Claims

exact text as granted — not AI-modified
1 - 37 . (Cancelled).  
     
     
         38 . An antibody or fragment thereof, which specifically binds to a macrophage stimulating protein (MSP) analog comprising at least one unpaired cysteine residue substituted with another amino acid, and which does not bind to wild-type MSP.  
     
     
         39 . The antibody or fragment according to  claim 38 , which is a monoclonal antibody.  
     
     
         40 . The antibody or fragment according to  claim 38 , which specifically binds to an MSP analog having a cysteine residue at position 677 of SEQ ID NO: 1 substituted with another amino acid.  
     
     
         41 . The antibody or fragment according to  claim 38 , which specifically binds to an MSP analog having a cysteine residue at position 672 of SEQ ID NO: 2 substituted with another amino acid.  
     
     
         42 . The antibody or fragment according to  claim 38 , which specifically binds to an analog of human MSP.  
     
     
         43 . The antibody or fragment according to  claim 38 , further comprising a detectable label conjugated to said antibody or fragment.  
     
     
         44 . A method for detecting the presence of a macrophage stimulating protein (MSP) analog in a biological sample, comprising: 
 incubating the sample with the antibody according to  claim 38  under conditions that allow binding of the antibody to the MSP analog, and    detecting the bound antibody.

Join the waitlist — get patent alerts

Track US2004260064A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.